Annual report pursuant to Section 13 and 15(d)

Balance Sheet

v2.4.0.8
Balance Sheet (USD $)
Dec. 31, 2013
Dec. 31, 2012
Current Assets:    
Cash and cash equivalents $ 18,688,031 $ 13,486,543
Marketable securities (note 3) 100,000 100,000
Prepaid expenses and other current assets (note 4) 507,165 188,808
Total Current Assets 19,295,196 13,775,351
Restricted Cash Equivalents (note 16) 196,130 1,091,801
Equipment, Net (note 6) 65,172 52,156
Total Assets 19,556,498 14,919,308
Current Liabilities:    
Accounts payable and accrued expenses (note 7) 933,758 851,837
Deferred Research and Development Arrangement (note 8) 833,630 1,626,000
Other Liabilities (note 9) 129,564 65,417
Warrant Liabilities (note 13) 5,034,058 2,842,065
Total Liabilities 6,931,010 5,385,319
Commitments and Contingencies (note 16)      
Stockholders' Equity (note 11):    
Preferred stock, par value $0.0001, 100,000,000 authorized shares, none issued and outstanding 0 0
Common stock, par value $0.0001, 500,000,000 authorized shares, 146,732,000 and 119,443,194 issued and 146,717,795 and 119,428,989 oustanding 14,673 11,944
Additional paid-in capital 85,449,932 72,861,738
Accumulated deficit during the development stage (72,810,707) (63,311,283)
Treasury stock, 14,205 shares, at cost (28,410) (28,410)
Total Stockholders' Equity 12,625,488 9,533,989
Total Liabilities and Stockholders' Equity $ 19,556,498 $ 14,919,308